Export boom for Tristel as revenues and profits rise
Tristel plc, which makes infection prevention products from its East Cambridgeshire base, continues to exploit refined technology in a record number of global markets.
In a trading update for the year ended June 30, Tristel confirmed a healthy rise in revenues and profits. It said results would be in line with market expectations as it expects to report turnover of £26 million (2018: £22.2m), with pre-tax profit before share-based payments of at least £5.5m (£4.7m).
Revenue from overseas markets increased by 26 per cent and contributed 55 per cent of total revenues – a record level and up from 51 per cent last time.
Revenue in the UK rose nine per cent. Sales of products using the company’s core chlorine dioxide technology grew by 22 per cent compared to non-core products which decreased by five per cent.
Tristel has continued to generate significant levels of cash and at June 30 cash balances were £4.2m.
CEO Paul Swinney said: “The balance of our business continues not only to shift towards our higher growth overseas markets but also towards our higher margin chlorine dioxide technology.”
The company expects to announce its preliminary results for the year in mid-October.